#141: Pfizer stops promoting Lipitor in US; moderate coffee intake protects against stroke; MagnaSafe: MRI with pacers, ICDs: Safe, a few minor issues; FAME II: FFR pinpoints stable CAD patients who do worse with OMT; whistleblower suit implicates Nissen
Pfizer stops promoting Lipitor in US; moderate coffee intake protects against stroke; MagnaSafe: MRI with pacers, ICDs: Safe, a few minor issues; FAME II: FFR pinpoints stable CAD patients who fare worse with OMT; whistleblower suit implicates Nissen, Cle
Source: Radio TheHeart.org - Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts
More News: Atorvastatin Calcium | Cardiology | Heart | Lipitor | Pfizer | Statin Therapy | Stroke | Zivast